The FDA in a post-Covid world

Covid-19 changed the R&D world. And it’s not going back to what it was before the pandemic. That’s particularly true at the FDA, which worked with developers to make it possible to continue trials when sites were shuttered around the world. We’ll explore what’s likely to stick now that the pandemic is winding down.

First name

Last name

Company

Job Title

Country

Questions & Comments

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.